Biomedical signs letter of intent on sale of hydrogen batteries
Biomedical Computer Technologies, a Hungarian drug and healthcare products wholesaler, said Tuesday it signed a letter of intent with J.M.B. Diffusion&Conseil on the sale of hydrogen batteries.
J.M.B. Diffusion&Conseil undertook to purchase 100,000 of the batteries as soon as mass production starts, and to buy an additional 200,000 batteries later.
Biomedical shares have been listed in category "B" of the Budapest Stock Exchange since June 29 of this year.
The company decided to list its shares in order to raise capital to fund the development of an invention gained through its earlier merger with Hydro-Tar that replaces battery acid with hydrogen.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.